Literature DB >> 1920087

Optimal extravascular dosing intervals.

P Veng-Pedersen1, N B Modi.   

Abstract

An explicit formula is presented for simple calculations of the dosing time, tau, that results in a steady-state peak-to-trough ratio of 2 in extravascular dosings. Contrary to other formulae presented, the calculations are guaranteed to be well bound in the percentage error (less than 1%) for any parameter value combination. It is shown that the biexponential dosing interval problem can be transformed into a general, dimensionless problem enabling a global error analysis in the approximation. The proposed formula is demonstrated in the calculation of an "optimal" dosing interval for quinidine. An algorithm and FORTRAN computer program OPTAU for exact calculation of tau and dosing simulations is also demonstrated in the quinidine example.

Entities:  

Mesh:

Year:  1991        PMID: 1920087     DOI: 10.1007/bf01061664

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  5 in total

Review 1.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

2.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

3.  Dosage intervals based on mean residence times.

Authors:  J G Wagner
Journal:  J Pharm Sci       Date:  1987-01       Impact factor: 3.534

4.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

5.  Comparative bioavaiability of four commercial quinidine sulfate tablets.

Authors:  J D Strum; J L Colaizzi; J M Jaffe; P C Martineau; R I Poust
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

  5 in total
  2 in total

1.  Investigation of absorption kinetics by the phase plane method.

Authors:  A Dokoumetzidis; P Macheras
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

2.  The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms.

Authors:  Selma Sahin; Leslie Z Benet
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.